Longevity & Anti-AgingResearch OnlyS

Pinealon

EDR Peptide

Russian peptide-bioregulator discussed for cognitive and aging-related signaling.

XRedditFacebook
Observational report only — live community data. Not medical advice. Does not recommend doses, protocols, or treatments.
Studies cited
3
Research grade
S
Community score
216

Trend index

Trackers
4,210

Overview

About Pinealon

Russian peptide-bioregulator discussed for cognitive and aging-related signaling.

Category
Longevity & Anti-Aging
Regulatory status
Research Only
Also known as
EDR Peptide
Self-reports
20

Community

What 20 users report

20 community reports

Positive 3% · Neutral 97% · Negative 0%

Most reported benefits

Cognition
145
Recovery
145

Most reported side effects

Injection site irritation
140

Dose distribution

Median: 200–400 mcg · Most common: 200–400 mcg

0–25
0
25–50
0
50–100
0
100–200
31
200–400
107
400–600
0
600–1000
0
1000–2000
5
2000+
2

How repeat users are trending

Among repeat reporters, 72% said they felt similar to their last entry, 28% more positive, and 0% more negative.

Overall, repeat reporters leaned more positive than their previous entry.

Median gap between entries: 105 days · Based on 18 repeat reporters

Research

Cited research (2)

Help

Frequently asked

What do PeptIQ users report about Pinealon?

This page summarizes 20 anonymized self-reports from PeptIQ users who track Pinealon, including commonly reported effects and co-tracked peptides. These are observational patterns, not clinical outcomes.

What research is cited for Pinealon?

2 sources are linked on this page, including PubMed articles, clinical trial registries, and FDA labels where applicable. Citations describe published research — not recommendations.

Is Pinealon safe to use?

This wiki does not assess safety or recommend use. Pinealon is listed as Research Only. Consult a licensed clinician for personal medical decisions.

What are the purported benefits and uses of Pinealon?

Research, primarily in animal models, suggests Pinealon may have a wide range of therapeutic potentials due to its ability to promote angiogenesis (formation of new blood vessels), stimulate collagen synthesis, and modulate inflammatory responses.

Source

What is the legal status of Pinealon?

Pinealon is not approved by the FDA for any human use. There is no legal basis for selling it as a drug, food, or dietary supplement in the United States. The FDA has classified Pinealon as a Category 2 bulk drug substance, which explicitly prohibits licensed compounding pharmacies from using it in compounded medications.

Source

What are the known or theoretical side effects and risks of Pinealon?

The safety and effectiveness of Pinealon have not been thoroughly evaluated in humans through rigorous clinical trials. This lack of human data means that safe dosages, short-term side effects, and long-term health consequences are largely unknown.

Source

What is the current state of research on Pinealon?

While there are over 200 published studies on Pinealon, the vast majority are animal or in vitro (cell) studies. These preclinical studies consistently show positive results across various tissue types. However, there is a significant lack of comprehensive human clinical trial data.

Source